Gaps in brand availability impact India’s pharmaceutical distribution: Vector Consulting Group…
Study reveals leading pharma companies face significant shortfalls in brand availability at chemists despite high inventory levels
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin receives “A-” leadership rating from CDP for climate change and water security
Lupin improves its CDP scores, reflecting progress in sustainability efforts, carbon footprint reduction, and water management
Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts…
Targeted therapies poised to transform Fragile X syndrome market with 4X growth by 2030
Sun Pharma amongst top 5% of global pharma companies in S&P Global Sustainability Yearbook 2025
Sun Pharma secures a spot in S&P Global’s Sustainability Yearbook 2025, reflecting its ESG commitments
Nectar Life Care introduces affordable anti-diabetic medications, expands market presence
Nectar Life Care expands its diabetes care portfolio with the launch of Dapagliflozin and other anti-diabetic formulations,…
GenAI adoption in India’s pharma sector signals operational shifts
EY report highlights AI-driven efficiency in pharma and healthcare industries
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Novel therapies and regulatory shifts drive growth in the Duchenne muscular dystrophy market, with exon-skipping therapies leading…
Obesity market to reach $173.5 billion sales in 7MM by 2031, forecasts GlobalData
Growing patient awareness and emerging therapies drive obesity drug market expansion across the US, Europe, and Japan
Zydus Lifesciences partners with Zhuhai Beihai Biotech for BEIZRAY commercialisation in the US
Zydus to handle US market launch of Albumin Solubilized Docetaxel injection
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global…